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1. Introduction 
Extracorporeal membrane oxygenation (ECMO) has been used more extensively since it 
became known as a potential bridge therapy, in patients with severe respiratory failure 
even under optimum conventional mechanical ventilator support, for further definite 
therapy. In the area of thoracic surgery, ECMO may have already become a useful life-
saving tool but studies on this treatment method remain scarce. Currently available 
reports and case series reveal that patients with massive hemoptysis or critical tracheal 
stenosis may be benefit from temporary ECMO therapy during the transition of emergent 
thoracic surgery. 
2. ECMO 
ECMO, also called extracorporeal life support, is a type of cardiopulmonary bypass. In 
May 1953, Gibbon (Gibbon, 1954) used artificial oxygenation and perfusion support for 
the first successful open heart surgery. Then it was first also effectively used in an adult 
patient with acute post-traumatic respiratory failure in 1972 (Hill et al., 1972). The 
following preliminary studies in 1970s suggested that ECMO could support oxygenation 
in patients with profound respiratory failure. Recently, the CESAR trial demonstrated that 
ECMO-based management can improve survival in patients with severe acute respiratory 
failure (Peek et al., 2009). As technological continues to advance, increasing indications 
and reports suggest that ECMO has a role to play in the transition of emergent thoracic 
surgery (Hsu et al., 2011). 
There are two types of ECMO: venous-arterial (VA) and venous-venous (VV) ECMO. VV 
ECMO supports isolated oxygenation failure, whereas VA ECMO provides hemodynamic 
and respiratory support. Although VA ECMO applies cardiopulmonary bypass, it has more 
complications due to the alteration of hemodynamic system. As a result, VV ECMO is 
typically used for respiratory failure while VA ECMO is used for cardiac failure. 
2.1 Initiation of ECMO 
ECMO is composed of a pump, an oxygenator and a heat exchanger. Once cannulation 
established, a large volume of blood is extracted from vessels by the mechanical pump. It 
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passes through the oxygenator and heat exchanger. The oxygenated blood is then finally re-
infused into the vessels. A complete circuit can be established in 40 minutes by an 
experience team. In VV ECMO, blood is drawn distally into the right atrium and returned 
into right atrium in an attempt to minimize recirculation. To achieve this, a drainage 
cannula is inserted in the right common femoral vein and the other infusion cannula is 
inserted in the right internal jugular vein. The tip of each cannula should be placed near the 
junction of the vena cava and the right atrium (fig. 1A). Alternatively, a double lumen 
cannula can be placed in one major vein (fig. 1B). 
 
 
Fig. 1. A: Cannulation of VV ECMO through the femoral vein and jugular vein.  
B: Alternative cannulation with a double lumen cannula through one major vein. 
In VA ECMO, blood is drawn from the common femoral vein and returned into the femoral 
artery (fig. 2A). Venous blood is oxygenated and pumped back into arterial circulation. As a 
result, both the heart and lungs are bypassed. The main concern in femoral artery 
cannulation is hypoxia of the ipsilateral leg. On the other hand, if native heart function was 
presence, the oxygenated blood may not reach the proximal aorta and this would result in 
hypoxia of the heart and upper body. Alternatively, carotid artery cannulation could be 
performed (fig. 2B). But the risk of watershed cerebral infarction increases when utilizing 
this method. Because ECMO draw a large volume of blood from vessels, the circuit should 
be primed with fluid. In most cases, the circuit is re-circulated with normal saline, heparin 
and crystalloid first. A typical regimen is normal saline 2000ml with heparin 2000units/liter. 
Once ECMO activated, packed red blood cells are transfused to compensate for the diluting 
effects of the priming fluid. There is no consensus about the total amount of units that 
should be transfused. This depends on the volume of the circuit, the perfusion status of 
patients and the underlying disease. Typically, the goal is to make the hematocrit more than 
30% and the mean arterial pressure more than 65mmHg. 
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Fig. 2. A: Cannulation of VA ECMO through the femoral vein and artery. B: Cannulation 
through the femoral vein and carotid artery. Each path has its own unique risks with 
regards to complications. 
2.2 Maintenance of ECMO 
During the extracorporeal circulation, thrombosis may occur in the circuit and induce an 
embolism because of blood surface interaction. As a result, anticoagulation with a 
continuous infusion of unfractionated heparin is mandatory. The anticoagulant is 
monitored by activated clotting time (ACT). In general, ACT should be titrated to 210 to 
230 seconds. The target should be decreased if the patients have a tendency towards 
bleeding. Platelets are continuously consumed because of the exposure to the foreign 
surface and the sheer force. As a result, platelet counts should also be monitored 
frequently. Sedation is definitely needed during ECMO. Adequate sedation can decrease 
the anxiety and suffering of patients and put the cardiopulmonary system at rest. The 
common agents for sedation in ICU are a continuous infusion of midazolam or propofol. 
Muscle relaxants could be added as well if the patients cannot tolerate use of mechanical 
ventilators well. Regardless, ECMO should only be utilized when patients are adequately 
sedated. 
2.3 Complications 
ECMO alters hemodynamic stability and induces a large amount of blood run in a device 
out of body. As a result, complications including localized tissues ischemia and hemostastic 
instability may occur. The VA ECMO also changes the direction of blood flow which may 
cause more complications than VV ECMO.  
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2.3.1 Complications in VV and VA ECMO 
Bleeding tendency is usually increased and profound bleeding may even become life- 
threatening. The occurrence rate of bleeding ranges from 7-34%. The contributing factors are 
due to the mandatory continuous infusion of unfractionated heparin, platelet consumption 
and sometimes the underline diseases such as massive hemoptysis and sepsis-related DIC. 
Effective management depends upon the sites and the causes of bleeding. For example, if 
the bleeding source is mucosa or gastrointestinal tract, medical management including 
correcting thrombocytopenia and transfusing with fresh frozen plasma may be necessary. If 
the bleeding persists or develops into profound bleeding, unfractionated heparin infusion 
must be withheld temporarily. After the bleeding stops, heparin should be added once again 
but the target ACT could be adjusted. On the other hand, bleeding from the surgical or 
device-insertion wounds, including ECMO cannulation site, often requires surgical 
intervention. This ranges from bedside electrocautery to surgical exploration to achieve 
bleeding stoppage. 
Thrombosis occurs at a rate of 8-17% and heparinization may help to reduce the incidence 
rate, but could also increase the potential for bleeding events. The balance between 
homeostasis and thrombosis require frequent clinical and laboratory monitoring. The 
pressure gradient across the oxygenator is a useful tool to be monitored, and a sudden 
change in the gradient may suggest a thrombus formation. 
Bleeding from a cannulated site is not uncommon. Vascular perforation and arterial 
dissection may occur during the placement of the cannula. Thus, the utilization of an 
experienced surgeon is quite important to avoid such complications. 
2.3.2 Complications only in VA ECMO 
In VA ECMO, oxygenated blood is infused into carotid artery or femoral artery, which 
forms a countercurrent to native blood flow from the left ventricle. As a result, the increased 
afterload may worsen the cardiac output of the left ventricle. This results in left ventricle 
distension, acute pulmonary hypertension and then even pulmonary hemorrhage. 
If the infusion cannula is placed in the femoral artery, not only the direction of blood flow of 
left ventricle, but also the blood flow of aorta is changed. Blood stasis in the aorta is induced 
if we are not able to maintain left ventricle output. Consequently, aorta thrombosis may 
develop. 
In this type of situation, blood flow from ECMO supplies lower extremities and visceral 
organs, where as the brain, heart and upper extremities are supplied by the heart itself. It is 
obvious that the oxygen saturation from the blood vessels supplied by ECMO is much 
higher than that by heart. Under this type of condition, cerebral and cardiac hypoxia may 
occur without being recognized if saturation is only monitored by blood sampling from the 
lower extremities. As a result, monitoring blood saturation during VA ECMO only by 
digital oxymetry or single arterial line should be avoided. 
2.4 Pumpless extracorporeal lung-assisted (pECLA) device 
Pumpless extracorporeal lung-assisted device, a novel type of ECMO, had been developed 
in recent 10 years. In 1967, Rashkind and colleagues first proposed the concept of pECLA 
(Rashkind et al. 1967). In recent years, the commercialized devices are available and become 
more and more popular in intensive care unit (Walles, 2007).  
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During setting up, the blood was drawn from the common femoral artery and sent back to 
the femoral vein. The pressure gradient driving blood flow in the device was supplied by 
heart pumping. As a result, pECLA dose not need a centrifugal or roller pump. In this 
way, it could be set more easily with lower cost and lower dose of heparin than 
conventional ECMO. However, the device was built to remove carbon dioxide in patient 
with acute respiratory distress syndrome under lung protective ventilation strategy. Since 
the blood was drawn from the artery, the oxygenated ability of pECLA was not superior 
to conventional ECMO. In the management of massive hemoptysis or critical tracheal 
stenosis, the main problem encountered was hypoxemic respiratory failure, but not 
hypercapnia. As a result, the application of pECLA in these patients may need more 
strictly selection. 
in summary, ECMO is a powerful therapeutic tool since it can replace the function of the 
heart and lungs. However, it has several potential complications and their risks increase as 
the duration of ECMO is prolonged. As a result, it can only serve as a salvage tool in life-
threatening conditions and as a bridge to the definite therapy. There are two types of 
ECMO, the VA type and the VV type. Although VA type can supply perfusion pressure, it 
obviously has more complications than the VV type. In the field of emergent thoracic 
surgery, which we will introduce in the following sections, the cardiac function is usually 
preservative. As a result, VV type ECMO is the first choice in emergent thoracic surgery. 
In thoracic surgery, there are 2 conditions, massive hemoptysis and major airway 
obstruction, where oxygenation is difficult to maintain. Under these conditions, if 
oxygenation could not be maintained by optimized mechanical ventilation or if the risk of 
life-threatening hypoxemia is very high, ECMO should be considered. 
3. Massive hemoptysis 
Massive hemoptysis is an important and potentially fatal event. It has been variably 
defined as an expectoration of blood amount ranging from 100-1000 ml in 24 hours 
(Dweik & Stoller, 1999). Since 200 ml of blood could fulfill the anatomical dead space of a 
major airway and 400 ml of blood might impede the oxygen exchange of alveolar space, 
massive hemoptysis can be defined as the expectorated blood volume that induces a life-
threatening condition by virtue of airway obstruction or severe blood loss (Garzon et al., 
1982). 
3.1 Conventional management of massive hemoptysis 
In the management of massive hemoptysis, protection of the non-bleeding lung and 
maintenance of adequate oxygen saturation are the major priorities. Then, the second step is 
to identify the source of the bleeding. The final step is the definite and specific treatment to 
prevent recurrent bleeding. Among the 3 steps, lung protection and maintenance of 
oxygenation are the most critical and could determine the outcome of patients. There are 
five methods for lung protection if the patient has continuous bleeding: decubitus position, 
selective intubation, double lumen intubation, Fogarty catheter placement and 
bronchoscope balloon tamponade (Lordan et al., 2003). 
At first, an attempt should be made to identify the bleeding side of the lung. After that, the 
patient should be laid with the bleeding side down to isolate the bleeding lung and ventilate 
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the normal lung. Single lung intubation could be performed if the amount of blood is too 
great (Gourin & Garzon, 1975). For right side bleeding, the bronchoscope could be placed in 
the left main bronchus and the endotracheal tube could be inserted in the left lung under the 
guidance of bronchoscope. For left side bleeding, the endotracheal tube could be placed in 
the right main bronchus simply by “pushing deeper”; however, this procedure has the risk 
of occluding the right upper lobe bronchus. 
Double lumen endotracheal tube is an alternative method for lung isolation. However, it has 
four major disadvantages and is not routinely performed in ICU. First, it is difficult for a 
physician to decide whether double lumen tube should be inserted if the patient only has 
mild hemoptysis at presentation. Second, it is difficult for an operator to insert a double 
lumen catheter if the patient was under a hypoxemic status with large amount of blood in 
the trachea and pharynx. Third, an experienced operator is mandated to avoid the serious 
result of mal positioning, especially during the transference of patients from ICU to an 
angiography room. The last disadvantage is that there are still not enough trials to 
definitively demonstrate whether the double lumen catheter procedure is effective. 
Fogarty catheter and bronchoscope balloon tamponade can be applied for lung isolation. A 
Fogarty catheter (14Fr/100cm length) can be placed over the bleeding bronchus under the 
guidance of bronchoscope. After inflated, the blood could be restricted in the bleeding side. 
Bronchoscope balloon tamponade may be more selective in restricting the blood. A 4-7 Fr 
balloon catheter is passed through the working channel of the bronchoscope and inflated to 
isolate the lung. However, both interventions need the guidance of bronchoscope. If the 
patient has massive bleeding, the large amount of blood in the trachea will impede the 
placement of a balloon catheter. 
3.2 ECMO in massive hemoptysis 
Several methods for lung isolation have been developed. Their aim is basically the same: 
to ventilate the good lung and to maintain adequate oxygenation. As a result, if a 
physician is able to establish a route for oxygenation without depending on inadequate 
ventilation support, the definite therapy could be applied more safely, even if we fail to 
protect the good lung. ECMO has such characteristics and might be useful in certain 
circumstances. 
If the patient had “abrupt desaturation”, ECMO can be implemented in 40 minutes by an 
experienced team. VV ECMO is the first choice, since most patients with massive 
hemoptysis are threatened by desaturation, rather than hypotension and shock. ECMO can 
be used as a bridge therapy for the definite treatment, such as angiography embolization 
and surgery. 
Comprehensive review for ECMO use in life-threatening hemoptysis is lacking, and there 
are still no studies in the related literature on this topic. Since no original study has been 
published, the experience in application of ECMO in certain patients is largely based on 
case reports and case series. As early as in 1974, Hanson and colleague reported the first 
case with pulmonary hemorrhage rescued by ECMO (Hanson et al., 1974). However, not 
until the 1990s was there was a study or report about the use of ECMO in certain 
situations. There may be two reasons for this lack of reporting. The first, there is still the 
argument about the benefit of ECMO in an adult population at that era. And the second, 
heparinization during  
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Author, year 
(list in reference)
Underlie disease Duration
(days)
ACT
(seconds)
Note 
Hernandez  
et al., 2002 
Wegener’s granuloma 9 150 Pediatric 
Kolovos  
et al., 2002 
Autoimmune disease or 
sepsis
4.9 160-180 Pediatric, 
Case No. 8 
Ahmed  
et al., 2004 
ANCA vasculitis 12 Full 
anticoagulation 
since day 3
 
Fujita  
et al., 2005 
Fulminant hepatitis 
s/p liver transplant 
4 N/A  
Agarwal  
et al., 2005 
Microscopic polyangitis 7 160-180  
Arokianathana  
et al., 2005 
Leptospirosis 7 N/A  
Sun  
et al., 2006 
Idiopathic Pulmonary 
Hemosiderosis
5 170-200  
Zhong  
et al., 2008 
Microscopic polyangitis 12 120-200  
Table 1. The application of ECMO in the 8 reported cases of diffuse alveolar hemorrhage. 
ECMO may precipitate further lung hemorrhage. In 2002, Kolovos and colleague reported 
the largest series and again raised the profile of reconsidering the role of ECMO in severe 
hemoptysis and pulmonary hemorrhage (Kolovos et al., 2002). They reported 8 children, 
aged 2 months to 18 years, with pulmonary hemorrhage due to sepsis or autoimmune 
disease received ECMO as the final therapeutic method because of severe respiratory 
failure. The eight children exhibited varying degrees of coagulopathy but still received 
heparinization. The ACT was controlled between 160 to 180 seconds. There was no 
profound hemorrhage after they received ECMO and all of them were weaned from ECMO 
successfully after pulmonary hemorrhage was controlled. After that report, although 
bleeding tendency was still thought to be a relative contraindication for ECMO, it seems that 
some patients with severe pulmonary hemorrhage could be rescued by ECMO use. 
As mentioned above, studies and reports in the related literature in this field are still scarce. 
To the best of our knowledge, there are only 13 reports about the application of ECMO in 
massive hemoptysis; 8 of them had diffused alveolar hemorrhage (DAH) (Table 1). In DAH, 
the use of ECMO has a stronger indication because there is no effective lung protective 
strategy. The patients in these reports were on ECMO support for 4 to 12 days. Heparin was 
used at a lower dosage to keep ACT around 120 to 200 seconds, instead of 210 to 230 
seconds. Alternatively, delaying the application of heparin seems to be a safe method. All of 
the patients in these case reports were successfully weaned from ECMO after the underlying 
causes of severe hemoptysis were under control. 
There are 5 reports about the use of ECMO in localized lung hemorrhage (Table 2). In 2 of 
them, the patients encountered abrupt desaturation during the procedure (bronchial artery 
embolization and operation), and lung protective therapy was difficult under that condition. 
Yuan et al. reported a patient with massive hemoptysis due to trauma and a double lumen 
endotracheal tube was intubated at the ER. However, the patient's clinical condition 
deteriorated and ECMO was used as a rescue method. In our experience, we have reported 
a case with bronchiectasis and massive hemoptysis (Hsu et al. 2011). The patient presented 
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with acute respiratory failure due to a rapid progression of severe hemoptysis. A total of 
4000 ml of packed red blood cells was transfused within 24 h to keep the hemoglobin level 
at around 10 mg/dl. The ventilator setting was in the volume control mode, at a positive 
end-expiratory pressure of 15 cm H2O, and a FiO2 of 100%; however, these setting only 
could maintain the arterial blood gas at a PaO2 of 62 mmHg. ECMO was applied due to 
high risk of transferring the patient from the intensive care unit to the angiography room 
and in-procedure mortality. After bronchial artery embolization successfully, ECMO was 
weaned 1 day later. No heparinization was performed because of the short term application 
of ECMO. The patient received left lower lobe lobectomy 2 weeks later due to intermittent 
small amount of hemoptysis. After the surgery, hemoptysis did not recur. He was 
discharged in ambulatory condition without any oxygen therapy. 
 
Author, year 
(list in reference)
Underlie disease Duration
(days)
ACT
(seconds)
Note
Fukui  
et al., 2006 
Pulmonary 
hypertension
12 40-50 since day 3
Bianchini  
et al., 2007 
Swan-Ganz
related trauma
2.5 N/A During operation 
Bedard  
et al., 2008 
Aorto-pulmonary 
fistula
N/A N/A During bronchial 
arterial embolization 
Yuan  
et al., 2008 
Double lumen 
related trauma
10 60-80
Hsu  
et al., 2011 
Bronchiectasis 1 No heparin
Table 2. The application of ECMO in the 4 reported cases of localized lung hemorrhage. 
The use of ECMO in massive hemoptysis may be beneficial for certain populations. 
However, there are still a number of debates about the use of ECMO, since available data is 
not sufficient in this field. First, setting up ECMO is an invasive procedure, and physicians 
may not maximize the “conventional therapy” before initiating ECMO. Second, 
heparinization is usually necessary in ECMO, but it may produce a more severe 
hemorrhage. Third, ECMO itself may bring about some complications, such as platelet 
consumption, bleeding and/or thromboembolism.  
In summary, maintenance of oxygenation is the most important object in the management of 
massive hemoptysis. ECMO should be used if all other methods fail or cannot be performed 
to maintain adequate oxygenation. However, there is still some uncertainty that needs to be 
addressed, such as the selection criteria of patients and the method of heparinization. Based 
on currently available evidence, the use of ECMO as a bridge tool for life-threatening 
hemoptysis can allow a patient to undergo definite therapy more safely. 
4. Critical tracheal stenosis 
Critical tracheal stenosis can be caused by either malignant or benign lesion. The symptoms 
may develop abruptly or slowly. In a chronic disease, such as malignancy, chronic 
inflammatory disease or collagen vascular disease, patients present with progressive 
dyspnea and stridor. While in acute conditions, such as blunt or penetrating neck trauma, 
patients may suffer from life-threatening asphyxia. The nature and severity of symptoms 
depends on the location and the magnitude of the lesion.  
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4.1 Conventional management of critical tracheal stenosis 
Most patients with tracheal stenosis present with chronic symptoms. However, a 50% 
reduction in the cross-sectional area of the trachea usually results in dyspnea on exertion, 
whereas a 75% reduction in the cross-sectional area produces dyspnea and stridor at rest. 
This means that when these symptoms develop, the airway has been severely 
compromised with impending life-threatening obstruction (Wood, 2002). The patient may 
be compensated for airway obstruction, but even a small amount of secretion can be 
lethal. As a result, the strategies of management are different according to the time point 
of diagnosis. 
If the tracheal stenosis is diagnosed early, physicians have enough time to make a complete 
study. The treatment options include surgical resection, reconstruction, therapeutic 
bronchoscopy with ablation and airway-stent placement. Before the management takes 
place, a secure airway could be performed utilizing an efficient method. The fiberoptic 
bronchoscope (FOB) provides a safe and effective way for airway control (Ovassapian, 
2001). With FOB, the lesion could be evaluated vividly and the residual lumen of airway 
could be estimated. After that, the largest endotracheal tube (ETT) that can pass the lumen 
should be chosen, since the airway pressure is inversely proportional to the inner diameter 
of the ETT. To avoid trauma to the airway or the trachea lesion, the ideal size of FOB is 1mm 
smaller than the internal diameter of ETT. The ideal-sized FOB should be used if available. 
After determining the size of ETT and FOB, intubation could be performed by experienced 
anaesthesiologist. 
If critical airway stenosis has developed, management will then become more difficult. The 
position of stenosis is important in this circumstance. For upper airway stenosis, FOB -
assisted intubation or emergent tracheotomy can stabilize the airway. For severe mid-level 
tracheal stenosis, intubation above the stenotic portion can be performed first. After positive 
pressure ventilation, the residual lumen will be mildly dilated. Then a smaller tracheal tube 
is placed under the assistance of FOB through trachea or directly placed into main bronchus 
by the surgeon during surgery. 
However, sometimes endotracheal intubation may be impossible, and even dangerous, 
possibly leading to complete airway obstruction. For most patients, emergent tracheotomy 
is ineffective because it cannot bypass the obstructive lesion. FOB may precipitate cough, 
bleeding or further mucosal edema and worsen the obstruction. There are only few choices 
for patients with this type of life-threatening major airway obstruction. One way is place the 
patient in a quiet room with very mild sedation and cool humidified oxygen. Nebulized 
epinephrine and dexamethasone help decrease the contraction and edema of the airway. It 
may temporary attenuate the symptoms and facilitate subsequent procedure, and FOB -
assisted intubation. 
4.2 ECMO in critical tracheal stenosis 
In patients with critical tracheal stenosis, the key to saving their lives is to maintain safe and 
efficient gas exchange. However, conventional anesthetic technique has a high risk of 
causing airway total occlusion, and the risk is inversely proportional to the residual lumen 
of the airway. As a result, if intubation is performed under a “back up” system, that can 
maintain adequate oxygenation even under total airway occlusion, it becomes safer for 
patients and less challenging to anaesthesiologists. Thus, ECMO serves as an ideal tool in 
this situation. 
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In paediatric surgery, an increasing number of reports and small-scale patient studies have 
pointed out that ECMO, either elective or emergent, serves as a good-bridge tool for trachea 
reconstruction. In neonates with congenital trachea anomalies, ECMO reduces the risk of 
surgery to allow more precise and unrushed airway reconstruction (Huang et al., 
2007)(Kunisaki et al., 2008). Elective ECMO uses in postoperative period also contribute to 
improve patients’ outcome (Connonlly & McGuirt, 2001).  
However, in the field of adults with critical trachea stenosis, we remain in the “case report 
era.” In 1999, Onozawa and colleagues first reported a case with critical airway obstruction 
due to thyroid cancer. The diameter of residual lumen of trachea was only 5mm. VA ECMO 
was applied before induction and the surgery was performed smoothly. After the partial 
resection of the thyroid tumor and the insertion of tracheostomy, ECMO was decannulated 
successfully. Following that, there are total 7 case reports with 9 adult patients involving the 
application of ECMO during critical tracheal stenosis surgery (table 3). These physicians 
attempted to intubate the patients reported but failed in two of them. One of them even 
experienced hypoxia cardiac arrest. Emergent ECMO was activated and this saved the 
patient’s life. Among them, the variable etiologies ranged from benign to malignant origin. 
The residual lumens of trachea are between 1mm to 5mm. The locations of trachea lesion 
distribute from 1.5cm above carina to upper level of trachea. VA ECMO was first used and 
more recently VV ECMO has been applied in cases of critical tracheal stenosis. Both types of 
ECMO can supply adequate oxygenation for performing the definite therapy. 
 
Author, year 
(list in reference)
Underlie 
disease 
Diameter & position 
of residual lumen 
Ecmo type Note 
Onozawa  
et al., 1999 
thyroid tumor 5mm VA ECMO  
Kurokawa  
et al., 2000 
tracheolysis 3mm VV ECMO  
Chen  
et al., 2004 
neurofibroma more than 5.5mm, 
5cm above carina 
N/A ETT, ECMO stand 
by only 
Zhou  
et al., 2007 
Post intubation 
trachea stenosis
2-3mm,  
1.5cm above carina 
VA ECMO ETT but failure, 
emergent ECMO 
Leiomyoma 1mm,  
6cm below vocal 
cords 
VA ECMO  
Jeon  
et al., 2009 
Thyroid tumor N/A (3x4 cm) VV ECMO  
Smith et al., 2009 Papilloma N/A ( 2.5x2.8 cm), 
2.5cm above carina 
VV ECMO  
Papilloma N/A, extend 2 cm 
below vocal cords to 
just above carina 
VV ECMO Bronchoscope 
ETT related 
hypoxic cardiac 
arrest 
Shao  
et al., 2009 
Bilateral 
nodular goiter 
5mm,  VA ECMO  
Table 3. The application of ECMO in critical airway stenosis during surgery 
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In summary, although there is still no original study published in this field, the related case 
reports have provided useful information. If the residual lumen of trachea is less than 5mm 
or the ETT cannot pass the lesion, a “stand by” ECMO should be considered before 
anaesthesia induction. VV ECMO is preferred since it can maintain adequate oxygenation 
with fewer complications. 
And finally, it is worth noting that the criteria for patient selection still needs further 
investigation to demonstrate the benefits of ECMO as a bridge therapy in critical trachea 
stenosis. The cost-effectiveness of this method is also worthy of further investigation. Before 
a definitive conclusion can be made, ECMO should be kept in mind as one option for 
clinical physicians when handling a patient with critical tracheal stenosis. 
5. Conclusion 
During the transition of emergent thoracic surgery, the most important objective is to 
maintain vital signs, ensuring that they are stable. However, in cases of massive hemoptysis 
and critical airway stenosis, it remains difficult for physicians to achieve adequate 
oxygenation since these conditions share the same challenge: difficult airway maintenance. 
In this field, ECMO serves as the rationale option if conventional therapy cannot achieve 
adequate oxygenation. Due to the lack of an original study, the role of ECMO in the 
transition of emergent thoracic surgery still deserves further investigation regarding its 
utilization and cost-effectiveness. Based on the current evidence available, ECMO could 
make the transition of emergent thoracic surgery safer. 
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